# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
B of A Securities analyst Adam Ron maintains Oscar Health (NYSE:OSCR) with a Buy and raises the price target from $22 to $25.
Wells Fargo analyst Stephen Baxter maintains Oscar Health (NYSE:OSCR) with a Overweight and raises the price target from $20...
Goldman Sachs analyst Nathan Rich maintains Oscar Health (NYSE:OSCR) with a Neutral and raises the price target from $16 to ...
Raymond James analyst John Ransom initiates coverage on Oscar Health (NYSE:OSCR) with a Outperform rating and announces Pric...